Tobramycin Injectable (Iv, Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV, IM)
Available Strengths: 10 mg/mL, 40 mg/mL, 80 mg/mL
Reference Brands: Bethkis, Tobi (US)
Category: Antibiotics
Tobramycin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing faulty protein production and bacterial death. It is effective against serious gram-negative infections, including Pseudomonas. Benefits include rapid bacterial eradication, broad-spectrum activity, and suitability for severe infections in hospital settings, when used under proper supervision. Tobramycin Injectable (IV, IM) is available in Injectable (IV, IM) and strengths such as 10 mg/mL, 40 mg/mL, 80 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tobramycin Injectable (IV, IM) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tobramycin Injectable (IV, IM) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Tobramycin injectable is approved in the EU and US for severe gram-negative bacterial infections, including Pseudomonas aeruginosa. In the EU, brands like Tobramycin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality control, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its potent activity and toxicity risks, strict prescribing, administration protocols, and monitoring are enforced. For expert regulatory support and dossier management, visit PharmaTradz. We ensure seamless market access, adhering to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Minocycline Hydrochloride
Strength:
50 mg, 75 mg, 100 mg, 20 mg/m
Form: Tablets/ capsules/ Injectable
Reference Brands: Minocin (USA), Solodyn (USA)
View DetailsTetracycline Hydrochloride
Strength:
250 mg, 500 mg
Form: Tablets, Capsules
Reference Brands: Achromycin (USA)
View DetailsOmadacycline
Strength:
100 mg, 150 mg
Form: Tablet/ Injection
Reference Brands: Nuzyra (USA/EU)
View DetailsNitrofurantoin
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Macrobid (USA), Macrodantin (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers